Details for New Drug Application (NDA): 020526
✉ Email this page to a colleague
NDA 020526 describes GYNE-LOTRIMIN 3 COMBINATION PACK, which is a drug marketed by Bayer Healthcare Llc and is included in one NDA. Additional details are available on the GYNE-LOTRIMIN 3 COMBINATION PACK profile page.
The generic ingredient in GYNE-LOTRIMIN 3 COMBINATION PACK is clotrimazole. There are eleven drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the clotrimazole profile page.
The generic ingredient in GYNE-LOTRIMIN 3 COMBINATION PACK is clotrimazole. There are eleven drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the clotrimazole profile page.
Summary for 020526
| Tradename: | GYNE-LOTRIMIN 3 COMBINATION PACK |
| Applicant: | Bayer Healthcare Llc |
| Ingredient: | clotrimazole |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020526
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM, TABLET;TOPICAL, VAGINAL | Strength | 1%,200MG | ||||
| Approval Date: | Jul 29, 1996 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
